New verticilides, inhibitors of acyl-CoA:cholesterol acyltransferase, produced by Verticillium sp. FKI-2679

Journal of Antibiotics

Volumn 65, Issue 5, 2012, Pages 255-262

  Ohshiro, Taichi ^a   Matsuda, Daisuke ^a   Kazuhiro, Takeuchi ^a   Uchida, Ryuji ^a   Nonaka, Kenichi ^a   Masuma, Rokuro ^a   Tomoda, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

acyl CoA:cholesterol acyltransferase; cyclodepsipeptide; fungal metabolite; inhibitor; verticilide; Verticillium

Indexed keywords

ACYL COA:CHOLESTEROL ACYLTRANSFERASE 1; ACYL COA:CHOLESTEROL ACYLTRANSFERASE 2; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CYCLODEPSIPEPTIDE; UNCLASSIFIED DRUG; VERTICILIDE A2; VERTICILIDE A3; VERTICILIDE B1;

ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; FERMENTATION; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOLVENT EXTRACTION; VERTICILLIUM;

ANIMALS; CERCOPITHECUS AETHIOPS; CHO CELLS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; DEPSIPEPTIDES; ENZYME INHIBITORS; FERMENTATION; INHIBITORY CONCENTRATION 50; SOIL MICROBIOLOGY; STEROL O-ACYLTRANSFERASE; VERTICILLIUM;

FUNGI; VERTICILLIUM SP.;

EID: 84861608137     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2012.12     Document Type: Article

References (34)

1. Sliskovic, D. R., Picard, J. A. & Krause, B. R. ACAT inhibitors: The search for a novel and effective treatment of hypercholesterolemia and atherosclerosis. Prog. Med. Chem. 39, 121-171 (2002).
2. Alegret, M., Llaverias, G. & Silvestre, J. S. Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs. Methods Find. Exp. Clin. Pharmacol. 26, 563-586 (2004).
3. Miyazaki, A., Kanome, T. & Watanabe, T. Inhibitors of acyl-coenzyme A: Cholesterol acyltransferase. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5, 463-469 (2005).
4. Chang, C. C., Huh, H. Y., Cadigan, K. M. & Chang, T. Y. Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 268, 20747-20755 (1993).
5. Anderson, R. A. et al. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 273, 26747-26754 (1998).
6. Cases,S.et al. ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273, 26755-26764 (1998).
7. Oelkers, P., Behari, A., Cromley, D., Billheimer, J. T. & Sturley, S. L. Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J. Biol. Chem. 273, 26765-26771 (1998).
8. Parini, P. et al. ACAT2 is localized to hepatocytes and is the major cholesterolesterifying enzyme in human liver. Circulation 110, 2017-2023 (2004).
9. Yagyu, H. et al. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J. Biol. Chem. 275, 21324-21330 (2000).
10. Accad, M. et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Invest. 105, 711-719 (2000).
11. Fazio, S. et al. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J. Clin. Invest. 107, 163-171 (2001).
12. Buhman, K. K. et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat. Med. 6, 1341-1347 (2000).
13. Willner, E. L. et al. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl Acad. Sci. USA 100, 1262-1267 (2003).
14. Lada, A. T. et al. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: Individual ACAT uniqueness. J. Lipid Res. 45, 378-386 (2004).
15. Ohshiro, T., Rudel, L. L., Omura, S. & Tomoda, H. Selectivity of microbial acyl-CoA: Cholesterol acyltransferase inhibitors toward isozymes. J. Antibiot. 60, 43-51 (2007).
16. Ikenoya, M. et al. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis 191, 290-297 (2007).
17. Tomoda, H. & Omura, S. Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms. Pharmacol. Ther. 115, 375-389 (2007).
18. Sakai, K. et al. Selective inhibition of acyl-CoA:cholesterol acyltransferase 2 isozyme by flavasperone and sterigmatocystin from Aspergillus species. J. Antibiot. 61, 568-572 (2008).
19. Ohshiro, T. & Tomoda, H. Isoform-specific inhibitors of ACATs: Recent advances and promising developments. Future Med. Chem. 3, 2039-2061 (2011).
20. Monma, S. et al. Verticilide: Elucidation of absolute configuration and total synthesis. Org. Lett. 8, 5601-5604 (2006).
21. Shiomi, K. et al. Verticilide, a new ryanodine-binding inhibitor, produced by Verticillium sp. FKI-1033. J. Antibiot. 63, 77-82 (2010).
22. Namatame, I., Tomoda, H., Si, S., Yamaguchi, Y., Masuma, R. & Omura, S. Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979. J. Antibiot. 52, 1-6 (1999).
23. Namatame, I., Tomoda, H., Tabata, N., Si, S. & Omura, S. Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages. J. Antibiot. 52, 7-12 (1999).
24. Matsuda, D. et al. New beauveriolides produced by amino acid-supplemented fermentation of Beauveria sp. FO-6979. J. Antibiot. 57, 1-9 (2004).
25. Tomoda, H. et al. Inhibition of acyl-CoA: Cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. J. Antibiot. 45, 1626-1632 (1992).
26. Tomoda, H. et al. New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305. J. Antibiot. 45, 1207-1215 (1992).
27. Kanaoka, M., Isogai, A. & Suzuki, A. Bassianolide, a new insecticidal cyclodepsipeptide from Beauveria bassiana and Verticillium lecanii. Agric. Biol. Chem. 43, 629-635 (1979).
28. Von Arx, J. A. The Genera of Fungi Sporulating in Pure Culture, 3rd edn. (Verlag J Cramer: Vaduz, 1981).
29. Tardif, J. C. et al. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110, 3372-3377 (2004).
30. Nissen, S. E. et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med. 354, 1253-1263 (2006).
31. Meuwese, M. C. et al. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: The CAPTIVATE randomized trial. JAMA 301, 1131-1139 (2009).
32. Ohshiro, T. et al. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 31, 1108-1115 (2011).
33. Namatame, I., Tomoda, H., Ishibashi, S. & Omura, S. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. Proc. Natl Acad. Sci. USA 101, 737-742 (2004).
34. Jacobson, E., Granville, W. C. & Foss, C. E. Color Harmony Manual. 4th edn Container of America: Chicago, USA, (1958).